Susan Altschuller
Director of Finance/CFO at CEREVEL THERAPEUTICS HOLDINGS, INC.
Net worth: 711 530 $ as of 30/04/2024
Susan Altschuller active positions
Companies | Position | Start | End |
---|---|---|---|
CEREVEL THERAPEUTICS HOLDINGS, INC. | Director of Finance/CFO | 15/05/2023 | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Director/Board Member | - | - |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Director of Finance/CFO | 01/05/2023 | - |
Career history of Susan Altschuller
Former positions of Susan Altschuller
Companies | Position | Start | End |
---|---|---|---|
IMMUNOGEN, INC. | Director of Finance/CFO | 20/07/2020 | 23/12/2022 |
ALEXION PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2018 | 01/04/2020 |
Corporate Officer/Principal | 01/04/2020 | 01/07/2020 | |
BIOVERATIV INC | Public Communications Contact | 01/08/2016 | 01/01/2018 |
BIOGEN INC. | Investor Relations Contact | - | - |
Training of Susan Altschuller
Tulane University (Louisiana) | Undergraduate Degree |
Illinois Institute of Technology | Doctorate Degree |
MIT Sloan School of Management | Masters Business Admin |
Statistics
International
United States | 11 |
Operational
Director of Finance/CFO | 3 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 4 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
BIOGEN INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
Private companies | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Process Industries |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Health Technology |
- Stock Market
- Insiders
- Susan Altschuller
- Experience